These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35439947)

  • 1. Blinded sample size re-estimation in a comparative diagnostic accuracy study.
    Stark M; Hesse M; Brannath W; Zapf A
    BMC Med Res Methodol; 2022 Apr; 22(1):115. PubMed ID: 35439947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculation and re-estimation based on the prevalence in a single-arm confirmatory diagnostic accuracy study.
    Stark M; Zapf A
    Stat Methods Med Res; 2020 Oct; 29(10):2958-2971. PubMed ID: 32299298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size recalculation based on the prevalence in a randomized test-treatment study.
    Hot A; Benda N; Bossuyt PM; Gerke O; Vach W; Zapf A
    BMC Med Res Methodol; 2022 Jul; 22(1):205. PubMed ID: 35879675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size re-estimation in paired comparative diagnostic accuracy studies with a binary response.
    McCray GPJ; Titman AC; Ghaneh P; Lancaster GA
    BMC Med Res Methodol; 2017 Jul; 17(1):102. PubMed ID: 28705147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial.
    Tavernier E; Giraudeau B
    PLoS One; 2015; 10(7):e0132578. PubMed ID: 26173007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths.
    Igeta M; Matsui S
    Stat Med; 2022 Dec; 41(29):5622-5644. PubMed ID: 36148560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
    Xu J; Yu M
    Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
    Harden M; Friede T
    Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized test-treatment studies with an outlook on adaptive designs.
    Hot A; Bossuyt PM; Gerke O; Wahl S; Vach W; Zapf A
    BMC Med Res Methodol; 2021 Jun; 21(1):110. PubMed ID: 34074263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded sample size re-estimation for recurrent event data with time trends.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adaptive approach to designing comparative diagnostic accuracy studies.
    Wu C; Liu A; Yu KF
    J Biopharm Stat; 2008; 18(1):116-25. PubMed ID: 18161544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Practical Perspective: Application of the Generalized Approach for Adaptive Design.
    Wang J; Li J; Shu Y; Su X
    Ther Innov Regul Sci; 2020 Jan; 54(1):167-170. PubMed ID: 32008229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinded sample size reestimation for negative binomial regression with baseline adjustment.
    Zapf A; Asendorf T; Anten C; Mütze T; Friede T
    Stat Med; 2020 Jun; 39(14):1980-1998. PubMed ID: 32207171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplification or simulation: Power calculation in clinical trials.
    Huang C; Li P; Martin CR
    Contemp Clin Trials; 2022 Feb; 113():106663. PubMed ID: 34958933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations.
    Kunz CU; Stallard N; Parsons N; Todd S; Friede T
    Biom J; 2017 Mar; 59(2):344-357. PubMed ID: 27886393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal adaptive group sequential design with flexible timing of sample size determination.
    Cui L; Zhang L; Yang B
    Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends.
    Asendorf T; Henderson R; Schmidli H; Friede T
    Stat Med; 2019 Apr; 38(9):1503-1528. PubMed ID: 30575061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.